United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 9, 2026 · Filed Jun 10, 2026

On Jun 9, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$549.32 for US$5.22M under a trading plan, leaving 40,513 shares. Filed Jun 10, 2026 (Form 4).

Sold
9,500 shares
Price
US$549.32 average (US$544.69 to US$552.89)
Value
US$5.22M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 9, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 9, 2026Common StockSale491US$544.6949,522Direct
Jun 9, 2026Common StockSale916US$545.6648,606Direct
Jun 9, 2026Common StockSale1,534US$546.6647,072Direct
Jun 9, 2026Common StockSale1,499US$547.6745,573Direct
Jun 9, 2026Common StockSale280US$548.8445,293Direct
Jun 9, 2026Common StockSale480US$549.7744,813Direct
Jun 9, 2026Common StockSale1,320US$551.3543,493Direct
Jun 9, 2026Common StockSale2,760US$552.4540,733Direct
Jun 9, 2026Common StockSale220US$552.8940,513Direct

Source

View original at SEC

Related